BDBM387836 US10294227, Code 585::tert-butyl N-[4-[4-amino-1-[2-(4-methoxy-1-piperidyl)ethyl]pyrazolo[3,4-d]pyrimidin-3-yl]-2-methoxy-phenyl]carbamate (593)

SMILES COC1CCN(CCn2nc(-c3ccc(NC(=O)OC(C)(C)C)c(OC)c3)c3c(N)ncnc23)CC1

InChI Key InChIKey=NTVNACFXAFFJQX-UHFFFAOYSA-N

Data  15 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 15 hits for monomerid = 387836   

TargetTyrosine-protein kinase ABL1(Human)
University Court of The University of Edinburgh

US Patent
LigandPNGBDBM387836(tert-butyl N-[4-[4-amino-1-[2-(4-methoxy-1-piperid...)
Affinity DataIC50: 550nMAssay Description:Compound IC50 values were determined from 10-point, 1:3 dilution curves starting at either 100 μM or 10 μM with 10 μM ATP, by Reaction...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase Blk(Human)
University Court of The University of Edinburgh

US Patent
LigandPNGBDBM387836(tert-butyl N-[4-[4-amino-1-[2-(4-methoxy-1-piperid...)
Affinity DataIC50: 10nMAssay Description:Compound IC50 values were determined from 10-point, 1:3 dilution curves starting at either 100 μM or 10 μM with 10 μM ATP, by Reaction...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetProtein-tyrosine kinase 6(Human)
University Court of The University of Edinburgh

US Patent
LigandPNGBDBM387836(tert-butyl N-[4-[4-amino-1-[2-(4-methoxy-1-piperid...)
Affinity DataIC50: 55nMAssay Description:Compound IC50 values were determined from 10-point, 1:3 dilution curves starting at either 100 μM or 10 μM with 10 μM ATP, by Reaction...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
University Court of The University of Edinburgh

US Patent
LigandPNGBDBM387836(tert-butyl N-[4-[4-amino-1-[2-(4-methoxy-1-piperid...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compound IC50 values were determined from 10-point, 1:3 dilution curves starting at either 100 μM or 10 μM with 10 μM ATP, by Reaction...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase Fgr(Human)
University Court of The University of Edinburgh

US Patent
LigandPNGBDBM387836(tert-butyl N-[4-[4-amino-1-[2-(4-methoxy-1-piperid...)
Affinity DataIC50: 10nMAssay Description:Compound IC50 values were determined from 10-point, 1:3 dilution curves starting at either 100 μM or 10 μM with 10 μM ATP, by Reaction...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase FRK(Human)
University Court of The University of Edinburgh

US Patent
LigandPNGBDBM387836(tert-butyl N-[4-[4-amino-1-[2-(4-methoxy-1-piperid...)
Affinity DataIC50: 10nMAssay Description:Compound IC50 values were determined from 10-point, 1:3 dilution curves starting at either 100 μM or 10 μM with 10 μM ATP, by Reaction...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase Fyn(Human)
University Court of The University of Edinburgh

US Patent
LigandPNGBDBM387836(tert-butyl N-[4-[4-amino-1-[2-(4-methoxy-1-piperid...)
Affinity DataIC50: 10nMAssay Description:Compound IC50 values were determined from 10-point, 1:3 dilution curves starting at either 100 μM or 10 μM with 10 μM ATP, by Reaction...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase HCK(Human)
University Court of The University of Edinburgh

US Patent
LigandPNGBDBM387836(tert-butyl N-[4-[4-amino-1-[2-(4-methoxy-1-piperid...)
Affinity DataIC50: 10nMAssay Description:Compound IC50 values were determined from 10-point, 1:3 dilution curves starting at either 100 μM or 10 μM with 10 μM ATP, by Reaction...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase Lck(Human)
University Court of The University of Edinburgh

US Patent
LigandPNGBDBM387836(tert-butyl N-[4-[4-amino-1-[2-(4-methoxy-1-piperid...)
Affinity DataIC50: 10nMAssay Description:Compound IC50 values were determined from 10-point, 1:3 dilution curves starting at either 100 μM or 10 μM with 10 μM ATP, by Reaction...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase Lyn(Human)
University Court of The University of Edinburgh

US Patent
LigandPNGBDBM387836(tert-butyl N-[4-[4-amino-1-[2-(4-methoxy-1-piperid...)
Affinity DataIC50: 10nMAssay Description:Compound IC50 values were determined from 10-point, 1:3 dilution curves starting at either 100 μM or 10 μM with 10 μM ATP, by Reaction...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
University Court of The University of Edinburgh

US Patent
LigandPNGBDBM387836(tert-butyl N-[4-[4-amino-1-[2-(4-methoxy-1-piperid...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compound IC50 values were determined from 10-point, 1:3 dilution curves starting at either 100 μM or 10 μM with 10 μM ATP, by Reaction...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetPlatelet-derived growth factor receptor alpha(Human)
University Court of The University of Edinburgh

US Patent
LigandPNGBDBM387836(tert-butyl N-[4-[4-amino-1-[2-(4-methoxy-1-piperid...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compound IC50 values were determined from 10-point, 1:3 dilution curves starting at either 100 μM or 10 μM with 10 μM ATP, by Reaction...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
University Court of The University of Edinburgh

US Patent
LigandPNGBDBM387836(tert-butyl N-[4-[4-amino-1-[2-(4-methoxy-1-piperid...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compound IC50 values were determined from 10-point, 1:3 dilution curves starting at either 100 μM or 10 μM with 10 μM ATP, by Reaction...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
University Court of The University of Edinburgh

US Patent
LigandPNGBDBM387836(tert-butyl N-[4-[4-amino-1-[2-(4-methoxy-1-piperid...)
Affinity DataIC50: 10nMAssay Description:Compound IC50 values were determined from 10-point, 1:3 dilution curves starting at either 100 μM or 10 μM with 10 μM ATP, by Reaction...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase Yes(Human)
University Court of The University of Edinburgh

US Patent
LigandPNGBDBM387836(tert-butyl N-[4-[4-amino-1-[2-(4-methoxy-1-piperid...)
Affinity DataIC50: 10nMAssay Description:Compound IC50 values were determined from 10-point, 1:3 dilution curves starting at either 100 μM or 10 μM with 10 μM ATP, by Reaction...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2020
Entry Details
Go to US Patent